Adaptive Biotechnologies Corp
NASDAQ:ADPT
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Adaptive Biotechnologies Corp
NASDAQ:ADPT
|
US |
|
M
|
Matador Resources Co
XBER:7MR
|
US |
|
E
|
Epam Systems Inc
F:E3M
|
US |
|
C
|
Clariant AG
XHAM:CLRN
|
CH |
|
S
|
SATS Ltd
OTC:SPASF
|
SG |
|
B
|
BHP Group Ltd
F:BHP
|
AU |
|
Dicker Data Ltd
F:D0D
|
AU |
|
DNB Bank ASA
F:D1N
|
NO |
|
N
|
Neschen AG
F:NSN
|
DE |
|
C
|
Capital & Counties Properties PLC
OTC:CCPPF
|
UK |
|
V2X Inc
F:1V1
|
US |
|
Zip Co Ltd
ASX:Z1P
|
AU |
|
O
|
OP Bancorp
F:OP3
|
US |
|
E
|
EnBW Energie Baden Wuerttemberg AG
F:EBK
|
DE |
|
Grupo Bimbo SAB de CV
F:4GM
|
MX |
|
California Resources Corp
F:1CLD
|
US |
|
Allcargo Logistics Ltd
BSE:532749
|
IN |
Wall St Price Targets
ADPT Price Targets Summary
Adaptive Biotechnologies Corp
According to Wall Street analysts, the average 1-year price target for ADPT is 83.64 USD with a low forecast of 72.72 USD and a high forecast of 92.4 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is ADPT's stock price target?
Price Target
83.64
USD
According to Wall Street analysts, the average 1-year price target for ADPT is 83.64 USD with a low forecast of 72.72 USD and a high forecast of 92.4 USD.
What is the Revenue forecast for Adaptive Biotechnologies Corp?
Projected CAGR
19%
Over the last 7 years, the compound annual growth rate for Revenue has been 26%. The projected CAGR for the next 5 years is 19%.
What is the Gross Profit forecast for Adaptive Biotechnologies Corp?
Projected CAGR
19%
Over the last 7 years, the compound annual growth rate for Gross Profit has been 28%. The projected CAGR for the next 5 years is 19%.
